(Q35757723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

The pharmacogenomics of selective serotonin reuptake inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Artioli P

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

233-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500250

27 December 2019

exact match

0 references

cites work

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Progress and pitfalls: bipolar molecular linkage studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Pharmacogenetics and the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Pharmacogenomics of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Pharmacogenetics in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Complete coding sequence of human tryptophan hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Localization of human tryptophan hydroxylase (TPH) to chromosome 11p15.3----p14 by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Synthesis of serotonin by a second tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

A unique central tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

The functional role of monoamine oxidases A and B in the mammalian central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

A functional polymorphism in the monoamine oxidase A gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Rat beta 1-adrenergic receptor regulatory region containing consensus AP-2 elements recognizes novel transactivator proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Discriminative stimulus effects of centrally administered isoproterenol in rats: mediation by beta-1 adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Chromosomal organization of adrenergic receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

The role of dopamine in the mechanism of action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Multiple dopamine D4 receptor variants in the human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Evaluation of nefazodone as a serotonin uptake inhibitor and a serotonin antagonist in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Polymorphism in serotonin transporter gene associated with susceptibility to major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Heterotrimeric G proteins: organizers of transmembrane signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

SSRIs antidepressant activity is influenced by G beta 3 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Selective restoration of male fertility in mice lacking angiotensin-converting enzymes by sperm-specific expression of the testicular isozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Sib pair linkage analysis of renin gene haplotypes in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Association study of angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Raised levels of plasma interleukin-1beta in major and postviral depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Further evidence for the depressive effects of cytokines: anhedonia and neurochemical changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Major depression and activation of the inflammatory response system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

The role of the vagus nerve in cytokine-to-brain communication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Molecular genetics of the human cytochrome P450 monooxygenase superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Role of pharmacogenomics in individualising treatment with SSRIs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Beta-1-adrenergic receptor gene in major depression: influence on antidepressant treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Characterization of acute N-ethyl-3,4-methylenedioxyamphetamine (MDE) action on the central serotonergic system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Assignment of a serotonin 5HT-2 receptor gene (HTR2) to human chromosome 13q14-q21 and mouse chromosome 14

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Effects of anxiogenic drugs in rat forced swimming test.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Association between clozapine response and allelic variation in 5-HT2A receptor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Organization of the human serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Antidepressant activity and calcium signaling cascades

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on therapeutic outcome in affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Association Study of the Interleukin-1beta (C-511T) Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Inhibition and induction of cytochrome P450 and the clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Human cytochrome P450s: selectivity and measurement in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500250

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15111987%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference